BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Earnings

  Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal

  As part of a major reorganization, Vir Biotechnology has discontinued the bulk of its virology work and pivoted to cancer in an exclusive licensing deal with Sanofi.

  August 2, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Approvals

  GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer

  In pursuit of Merck’s blockbuster Keytruda, GSK’s Jemperli scored its own broad FDA label expansion, allowing its use in first-line endometrial cancer regardless of biomarker status.

  August 2, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  RSV Vaccine Makers Hit Hard by New CDC Guidelines

  GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus vaccine sales slumps thanks to recently updated CDC guidelines regarding the use of RSV shots in seniors.

  August 2, 2024

   · 

  3 min read

   · 

  Greg Slabodkin
• 

  Approvals

  Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors

  Approved under the regulator’s accelerated pathway, Tecelra is also the first new synovial sarcoma therapy in more than a decade, according to Adaptimmune Therapeutics.

  August 2, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pipeline

  Vertex Scraps Two Phase I AATD Candidates Following Disappointing Data

  Poor efficacy data for two early-stage candidates for the rare disease alpha-1 antitrypsin deficiency have convinced Vertex Pharmaceuticals to terminate their development.

  August 2, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• News

  CMR Surgical embarks on world-first paediatric clinical trial using Versius

  August 2, 2024

   · 

  5 min read
• News

  Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration

  August 2, 2024

   · 

  7 min read
• Drug Development

  New Clinical Data Highlights Efficacy of Seed Health’s VS-01 Vaginal Synbiotic in Establishing Protective and Optimal Vaginal Microbiome

  August 2, 2024

   · 

  6 min read
• Press Releases

  Elevar Therapeutics Granted Orphan Medicinal Product Designation by the European Medicines Agency for First-Line Systemic Therapy for Unresectable Hepatocellular Carcinoma

  August 2, 2024

   · 

  5 min read
• Press Releases

  Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

  August 2, 2024

   · 

  2 min read